Evaluation of Pain Relief and Bacterial Reduction After Using Calcium Hydroxide With Mesoporous Silica Nanoparticles as an Intracanal Medicament in Necrotic Mandibular Molars: A Randomized Controlled Clinical Trial
Evaluation of Post-operative Pain and Bacterial Load Reduction After Incorporation of Mesoporous Silica Nanoparticles in Calcium Hydroxide Intracanal Medicament in Mandibular First Molar Teeth With Necrotic Pulp. "Randomized Controlled Clinical Trial"
1 other identifier
interventional
42
1 country
1
Brief Summary
This study compares how well different root canal medications reduce pain and bacteria after treatment of lower molar teeth with necrotic pulp. It tests whether adding mesoporous silica nanoparticles-antibacterial particles-to calcium hydroxide makes the treatment more effective. Forty-two adult patients will be randomly assigned to receive either calcium hydroxide alone, nanoparticles alone, or a mix of both for one week during root canal therapy. measure patients' pain levels after 6h,12h,24,48h and 72 hours from treatment and the number of bacteria before and after treatment to see which method gives the best results. The goal is to make root canal treatments more comfortable and successful for future patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 25, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedJanuary 8, 2026
October 1, 2025
8 months
December 25, 2025
December 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative pain after application of different intracanal medications
measuring Post-operative pain by Numerical rate scale and pain level will be assigned to one of 4 categorical score: none(0) - mild(1-3), severe(7-10) after 6h,12h,24,48h
from 6 to 72 hours from the treatment
Secondary Outcomes (1)
bacterial load change after intracanal medication
immediately in the intervention and after 1 week
Study Arms (3)
The root canals will be filled with calcium hydroxide paste
ACTIVE COMPARATORusing calcium hydroxide paste as intracanal medication for 1week
The root canal will be filled with mesoporous silica nanoparticles paste.
ACTIVE COMPARATORusing mesoporous silica nanoparticles paste as intracanal medication for week
root canals will be filled with mesoporous silica nanoparticles with calcium hydroxide paste.
ACTIVE COMPARATORusing mesoporous silica nanoparticles with calcium hydroxide paste as intracanal medication for 1week
Interventions
root canals filled with calcium hydroxide paste as intracanal medication for 1week
root canals filled with mesoporous silica nanoparticles for 1 week
Root canal filled with Intracanal medication by combination between mesoporous silica nanoparticles with calcium hydroxide paste for one week.
Eligibility Criteria
You may qualify if:
- Patients with an age range between 18 to 40.
- No sex predilection.
- Patients with necrotic pulp.
- Patients able to sign informed consent.
- Restorable teeth.
- Positive patient's acceptance for participating in the study.
- Type III distal and mesial canal of first mandibular molar.
You may not qualify if:
- Pregnant females
- Medically compromised patients.
- Patients having analgesics before the treatment
- If antibiotics have been administrated during the past two weeks pre-operatively.
- Patients having bruxism or clenching
- Patients having sever malocclusion associated with traumatic occlusion.
- Teeth that have:
- Peri-apical radiolucency
- Root resorption.
- Pulp stones or calcifications.
- Previous endodontic treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Future University in Egypt
Cairo, New Cairo, 11835, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
December 25, 2025
First Posted
January 8, 2026
Study Start
September 1, 2025
Primary Completion
April 30, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
January 8, 2026
Record last verified: 2025-10